BD, Biocorp Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs
  Companies to Explore Opportunities to Integrate Biocorp’s Injay® Technology with BD UltraSafePlus™ Passive Needle Guard to Help Biopharmaceutical Manufacturers Capture and Transmit Self-Administered Injection Data.FRANKLIN LAKES, N.J., October 18, 2022 / B3C newswire / -- BD (Becton, Dickinson and Compan...
Source: pharmiweb.com